top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Assessing the impact of a safe and equitable biosimilar policy in the United States : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007
Assessing the impact of a safe and equitable biosimilar policy in the United States : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007
Soggetto topico Biologicals - United States
Pharmaceutical biotechnology - United States
Generic drugs - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States
Record Nr. UNINA-9910694419603321
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Biologics and biosimilars [[electronic resource] ] : balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009
Biologics and biosimilars [[electronic resource] ] : balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009
Pubbl/distr/stampa Washington : , : U.S. G.P.O., , 2010
Descrizione fisica 1 online resource (iv, 252 pages) : illustrations
Soggetto topico Drug development - Government policy - United States
Pharmaceutical biotechnology - Government policy - United States
Pharmaceutical biotechnology - United States
Biologicals - Government policy - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Biologics and biosimilars
Record Nr. UNINA-9910698589103321
Washington : , : U.S. G.P.O., , 2010
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Emerging safety science [[electronic resource] ] : workshop summary / / Sally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Emerging safety science [[electronic resource] ] : workshop summary / / Sally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Pubbl/distr/stampa Washington, D.C., : National Academies Press, c2008
Descrizione fisica xvi, 134 p. : ill. (some col.)
Disciplina 615/.10289
Altri autori (Persone) RobinsonSally
PoolRobert
GiffinRobert B
Soggetto topico Drugs - United States - Safety measures
Pharmaceutical biotechnology - United States
Drugs - United States - Design
Soggetto genere / forma Electronic books.
ISBN 1-281-30023-3
9786611300234
0-309-11013-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910454583503321
Washington, D.C., : National Academies Press, c2008
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Emerging safety science [[electronic resource] ] : workshop summary / / Sally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Emerging safety science [[electronic resource] ] : workshop summary / / Sally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Pubbl/distr/stampa Washington, D.C., : National Academies Press, c2008
Descrizione fisica xvi, 134 p. : ill. (some col.)
Disciplina 615/.10289
Altri autori (Persone) RobinsonSally
PoolRobert
GiffinRobert B
Soggetto topico Drugs - United States - Safety measures
Pharmaceutical biotechnology - United States
Drugs - United States - Design
ISBN 0-309-17817-7
1-281-30023-3
9786611300234
0-309-11013-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910782897703321
Washington, D.C., : National Academies Press, c2008
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Emerging safety science [[electronic resource] ] : workshop summary / / Sally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Emerging safety science [[electronic resource] ] : workshop summary / / Sally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Edizione [1st ed.]
Pubbl/distr/stampa Washington, D.C., : National Academies Press, c2008
Descrizione fisica xvi, 134 p. : ill. (some col.)
Disciplina 615/.10289
Altri autori (Persone) RobinsonSally
PoolRobert
GiffinRobert B
Soggetto topico Drugs - United States - Safety measures
Pharmaceutical biotechnology - United States
Drugs - United States - Design
ISBN 0-309-17817-7
1-281-30023-3
9786611300234
0-309-11013-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front Matter -- Reviewers -- Preface -- Contents -- Tables and Figures -- 1 Introduction -- 2 Investigative Toxicology: The State of the Art -- 3 Screening Technologies I: Human Cell-Based Approaches -- 4 Screening Technologies II: Toxicogenomics -- 5 Screening Technologies III: Metabolomics -- 6 Screening Technologies IV: Pharmacogenetics -- 7 Qualifying Biomarkers -- 8 Pharmacovigilance -- 9 Integration -- 10 The Future of Safety Science -- References -- Appendixes -- Appendix A: Workshop Agenda -- Appendix B: Speaker Biographies.
Record Nr. UNINA-9910809901503321
Washington, D.C., : National Academies Press, c2008
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Follow-on biologics [[electronic resource] ] : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007
Follow-on biologics [[electronic resource] ] : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007
Pubbl/distr/stampa Washington : , : U.S. G.P.O., , 2008
Descrizione fisica 1 electronic text (iv, 78 pages) : HTML, digital, PDF file
Collana S. hrg.
Soggetto topico Pharmaceutical biotechnology - Government policy - United States
Pharmaceutical biotechnology - United States
Pharmaceutical technology - Government policy - United States
Drug development - Government policy - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Follow-on biologics
Record Nr. UNINA-9910698695203321
Washington : , : U.S. G.P.O., , 2008
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Guidance for industry [[electronic resource] ] : manufacturing biological intermediates and biological drug substances using spore-forming microorganisms
Guidance for industry [[electronic resource] ] : manufacturing biological intermediates and biological drug substances using spore-forming microorganisms
Pubbl/distr/stampa Rockville, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, , [2007]
Descrizione fisica ii, 14 pages : digital, PDF file
Soggetto topico Intermediates (Chemistry)
Sporeforming bacteria - United States
Pharmaceutical biotechnology - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Guidance for industry
Record Nr. UNINA-9910698880003321
Rockville, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, , [2007]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Guidance for industry [[electronic resource] ] : drugs, biologics and medical devices derived from bioengineered plants for use in humans and animals
Guidance for industry [[electronic resource] ] : drugs, biologics and medical devices derived from bioengineered plants for use in humans and animals
Pubbl/distr/stampa Rockville, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, , [2002]
Descrizione fisica 1 electronic resource (i, 27 pages)
Soggetto topico Pharmaceutical biotechnology - United States
Medical instruments and apparatus - United States
Veterinary biologicals - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Guidance for industry
Record Nr. UNINA-9910696916803321
Rockville, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, , [2002]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Guidance for industry [[electronic resource] ] : Q5A viral safety evaluation of biotechnology products derived from cell lines of human or animal origin
Guidance for industry [[electronic resource] ] : Q5A viral safety evaluation of biotechnology products derived from cell lines of human or animal origin
Pubbl/distr/stampa Rockville, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : , : Center for Biologics Evaluation and Research, , [1998]
Descrizione fisica 1 online resource (i, 30 pages)
Soggetto topico Pharmaceutical biotechnology - United States
Biological products - Evaluation
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Guidance for industry
Record Nr. UNINA-9910699245503321
Rockville, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : , : Center for Biologics Evaluation and Research, , [1998]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, March 26, 2007
Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, March 26, 2007
Soggetto topico Biologicals - United States
Pharmaceutical biotechnology - United States
Generic drugs - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Safe and affordable biotech drugs
Record Nr. UNINA-9910694411303321
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui